Cerebrolysin
Also known as: FPF 1070
strong human dataNot FDA approved
Published Dose Range
Low5 mL/day
Typical10 mL/day
High30 mL/day
Porcine-derived peptide preparation. Approved in many European and Asian countries for stroke, TBI, and dementia. Dose is in mL of a standard formulation rather than mg.
Published Cycle Range
Short2 wks
Typical3 wks
Long4 wks
Typical protocol: 10-20 daily infusions followed by several weeks off.
Off-cycle: 8 weeks
Administration
Routesintramuscular, iv
FrequencyDaily during cycle
Preferred timingMorning
IM or slow IV infusion — not for subcutaneous use.
Safety Profile
Contraindications
- • Severe renal failure
- • Status epilepticus
- • Hypersensitivity to porcine proteins
Common side effects
- • Injection site reactions
- • Sweating
- • Dizziness
- • Agitation (dose-dependent)
Serious risks
- • Seizure risk in patients with epilepsy
- • Allergic reactions (porcine-derived)
Drug interactions
- • Additive effects with MAOIs and antidepressants
Pregnancy / breastfeeding
Not recommended during pregnancy
Common Misconceptions
- Not subcutaneous — must be given IM or as slow IV infusion
Commonly Stacked With
SemaxSelank
Next Steps
Sign in to calculate your dose, add this compound to your stack, and check for interactions with your current cabinet.